TAHIRA SIAL: Open Payments
NPI 1265494728 · EAST MEADOW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 33 payments from 10 companies in 2025. Trend: 2023 $698 · 2024 $517 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $107 |
| Corium, LLC | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $46 |
| Alkermes, Inc. | 1 | $16 |
Products named: AUSTEDO XR, Azstarys, CAPLYTA, INGREZZA, SPRAVATO, TRINTELLIX, FANAPT, REXULTI.
Industry payments across NY — which companies pay providers there.
